Ark Clinical Research
Better Research for a Better Life
29 employees · est. 2016 · Long Beach, United States
Delcath Systems
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of metastatic liver cancer.
86 employees · est. 1987 · New York, United States
Delcath Systems is the older company (2016 vs 1987); Delcath Systems is the larger of the two.
Side-by-Side Comparison
| Metric | Ark Clinical Research | Delcath Systems |
|---|---|---|
| Founded | ||
| Founded | 2016 | 1987 older |
| Headquarters | ||
| Headquarters | Long Beach, United States | New York, United States |
| Employees | ||
| Employees | 29 | 86 larger |
| Industry | ||
| Industry | Health Care | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $276.60M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 13 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical Research, Infectious Diseases, Vaccines, Metabolic Disorders, Liver Conditions, Cardiovascular Issues, Asthma, Allergies, Central Nervous System Disorders, Outpatient Clinical Trials, Respiratory Clinical Research, Internal Medicine, Dermatology Clinical Research, Late-phase Clinical Trials, COVID Vaccine | Interventional Oncology, Metastatic Liver Cancer, Medical Device, High-dose Chemotherapy, Clinical Development, Melphalan/HDS, CE Marked Device, European Market, FOCUS Pivotal Study, Hepatic Dominant Ocular Melanoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Directed Therapy, Drug Delivery, Specialty Pharmaceutical |
| Website | ||
| Website | arkclinicalresearch.com | delcath.com |
About Ark Clinical Research
Ark Clinical Research is a pioneering force in the field of clinical trials, dedicated to advancing medical knowledge and innovation across diverse medical domains. Established in 2016 and headquartered in the United States, the company focuses on transformative clinical trials in areas such as Infe...
About Delcath Systems
Delcath Systems, Inc. is an interventional oncology company with a focus on treating metastatic liver cancer. The company, listed on NASDAQ under the ticker symbol DCTH, specializes in the treatment of primary and metastatic liver cancers. Its proprietary product, Melphalan Hydrochloride for Injecti...
We will tell you when either one moves
BounceWatch watches Ark Clinical Research and Delcath Systems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ark Clinical Research and Delcath Systems — by email.
Frequently Asked Questions
Compare Ark Clinical Research with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ark Clinical Research on 13 Sep 2024, and Delcath Systems on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.